Mogo - MOGO Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Mogo in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MOGO shares.
View MOGO analyst ratings or view top-rated stocks.

2 brokerages have issued 1 year price targets for Mogo's stock. Their MOGO share price forecasts range from $3.75 to $10.00. On average, they predict the company's share price to reach $6.35 in the next twelve months. This suggests a possible upside of 982.9% from the stock's current price.
View analysts price targets for MOGO or view top-rated stocks among Wall Street analysts.

Mogo's stock was trading at $3.42 at the beginning of the year. Since then, MOGO shares have decreased by 82.9% and is now trading at $0.5864.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 22nd 2023.
View our MOGO earnings forecast.

Mogo Inc. (NASDAQ:MOGO) issued its earnings results on Wednesday, November, 10th. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.13) by $0.01. The company had revenue of $12.26 million for the quarter, compared to analysts' expectations of $11.26 million. Mogo had a negative trailing twelve-month return on equity of 21.81% and a negative net margin of 175.14%.

Mogo updated its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $52.13 million-$52.90 million, compared to the consensus revenue estimate of $52.03 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mogo investors own include Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Enerplus (ERF), Novan (NOVN), CNBX Pharmaceuticals (CNBX) and Hallador Energy (HNRG).

Mogo trades on the NASDAQ under the ticker symbol "MOGO."

Mogo's stock is owned by many different retail and institutional investors. Top institutional investors include Toroso Investments LLC (6.57%), Garnet Equity Capital Holdings Inc. (1.09%), ARS Investment Partners LLC (0.77%), Point72 Asset Management L.P. (0.77%), Renaissance Technologies LLC (0.14%) and Citadel Advisors LLC (0.00%).

Shares of MOGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MOGO stock can currently be purchased for approximately $0.59.

Mogo (NASDAQ:MOGO) has a market capitalization of $44.54 million and generates $45.89 million in revenue each year. The company earns $-26,500,000.00 in net income (profit) each year or ($1.35) on an earnings per share basis.

The company employs 344 workers across the globe.

Mogo's mailing address is 2100-401 WEST GEORGIA STREET, VANCOUVER BC, V6B 5A1. The official website for the company is www.mogo.ca. The company can be reached via phone at (604) 659-4380 or via email at investors@mogo.ca.